TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
S | %ret | 1 | 1 | 3 | -2 | -6 | -5 | -5 | -24 | -29 | -12 |
S | %wins | 100 | 100 | 67 | 100 | 100 | 67 | 89 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/29/14 16:26 | 5/27/14 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sullivan Timothy M | MA | O | VP Devel | M.d | 145 | 0.9037 | 5 | 161 | 25 | D | 188 | 308 | 52 | -54 | 11 | 18 | 14 | 15 | -6 | -13 | 2 | -7 | -17 | 17 | |
5/29/14 16:26 | 5/27/14 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sullivan Timothy M | MA | O | VP Devel | S.d | -439 | 2.73 | 5 | -161 | -87 | 25 | D | 188 | 308 | 52 | -54 | 11 | 18 | 14 | 15 | -6 | -13 | 2 | -7 | -17 | 17 |
11/12/10 16:53 | 11/10/10 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sullivan Timothy M | MA | O | VP Devel | S | -10 | 2.72 | 0 | -4 | -13 | 25 | D | -66 | -43 | -47 | -15 | -15 | -2 | 1 | 3 | -1 | -4 | -16 | -6 | -8 | -43 |
5/16/08 18:15 | 5/15/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sullivan Timothy M | MA | O | VP Devel | S | -63 | 14.95 | 1 | -4 | -18 | 19 | D | 286 | 70 | 22 | 37 | 19 | 13 | 2 | 0 | 0 | 0 | -2 | -2 | -48 | -61 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |